The present invention provides compounds of the following formula and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs).
These compounds and compositions are useful as pharmaceutical agents.
本发明提供了以下式子的化合物和药物组合物,它们是A2B
腺苷受体(ARs)的选择性拮抗剂。这些化合物和组合物可作为药物代理使用。